Globela Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.50 Cr
- Paid Up Capital ₹ 0.99 K
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 44.12 Cr
About Globela Laboratories
Globela Laboratories Private Limited (GLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 February 2022 (Two years and 11 months 30 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.50 Cr and a paid-up capital of Rs 0.99 K .
The company currently has active open charges totaling ₹44.12 Cr.
Priyank Vaghashia and Bhanubhai Vaghashia serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304GJ2022PTC129637
- Company No.
129637
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Globela Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyank Vaghashia  | Director | 24-Feb-2022 | Current |
| Bhanubhai Vaghashia | Director | 24-Feb-2022 | Current |
Financial Performance of Globela Laboratories.
Globela Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Globela Laboratories?
In 2023, Globela Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Globela Pharma Private LimitedPriyank Vaghashia and Bhanubhai Vaghashia are mutual person
- Globela Industries Private Limited
Priyank Vaghashia and Bhanubhai Vaghashia are mutual person
Globela Biotech LlpPriyank Vaghashia is a mutual person
Charges (Loans)
₹44.12 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 44.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2022 | Axis Bank Limited | ₹22.06 Cr | Open |
| 25 Mar 2022 | Axis Bank Limited | ₹22.06 Cr | Open |
How Many Employees Work at Globela Laboratories?
Unlock and access historical data on people associated with Globela Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Globela Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globela Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.